India on Saturday said it is closely examining the implications of a recent ruling by the US Supreme Court that struck down former US President Donald Trump’s sweeping global tariffs.
In its initial response, the Commerce Ministry said it has taken note of both the court’s judgement and subsequent announcements made by the US administration.
“We have noted the US Supreme Court judgement on tariffs yesterday (Friday). US President Donald Trump has also addressed a press conference in this regard,” the ministry said.
“Some steps have been announced by the US administration. We are studying all these developments for their implications,” it added.
What did the US Supreme Court rule?
On Friday, the conservative-majority court ruled 6–3 that a 1977 law relied upon by Trump to impose sudden tariffs on individual countries does not authorise the President to impose such sweeping duties.
The judgement marked a significant setback to Trump’s tariff policy, which had reshaped trade relations with several countries.
Responding to the ruling, Trump criticised members of the court, saying he was “ashamed” of certain justices and describing the verdict as disappointing.
Fresh tariffs under Section 122
Following the court’s decision, Trump announced new tariffs using Section 122 of the Trade Act of 1974. The provision allows the US President to impose temporary tariffs of up to 15 per cent for a maximum period of 150 days to address large and serious balance-of-payments deficits.
Under this route, a new 10 per cent global tariff has been imposed on imports into the United States. Trump said the revised order would be effective almost immediately.
US Treasury Secretary Scott Bessent, speaking at the Economic Club of Dallas, said the alternative mechanism would result in virtually unchanged tariff revenue in 2026.
Impact on India
Under the revised order, India faces a tariff rate of 10 per cent, reduced from the earlier 18 per cent under Trump’s broader tariff framework.
The new duty is scheduled to take effect from February 24 for a period of 150 days. Exemptions will continue for sectors subject to separate investigations, including pharmaceuticals, as well as goods entering the US under the US-Mexico-Canada Agreement framework.
India has not announced any retaliatory measures and has indicated that it is currently assessing the trade and economic implications of the US decisions.